UPAR induces expression of transforming growth factor β and interleukin-4 in cancer cells to promote tumor-permissive conditioning of macrophages

American Journal of Pathology

Volumn 184, Issue 12, 2014, Pages 3384-3393

  Hu, Jingjing ^a   Jo, Minji ^a   Eastman, Boryana M ^a   Gilder, Andrew S ^a   Bui, Jack D ^a   Gonias, Steven L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; BIOLOGICAL MARKER; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA; UROKINASE RECEPTOR; ARGINASE; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL LINE; CANCER GROWTH; GLIOBLASTOMA; IMMUNOBLOTTING; MACROPHAGE; PANCREAS CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT; ANIMAL; BRAIN TUMOR; CELL PROLIFERATION; COCULTURE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; METABOLISM; METASTASIS; MOUSE; PANCREAS TUMOR; PHENOTYPE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; ARGINASE; BIOMARKERS, TUMOR; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; COCULTURE TECHNIQUES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; INFLAMMATION; INTERLEUKIN-4; MACROPHAGES; MICE; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; PHENOTYPE; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84913556209     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.08.003     Document Type: Article

References (54)

1. J. Houghton, C. Stoicov, S. Nomura, A.B. Rogers, J. Carlson, H. Li, X. Cai, J.G. Fox, J.R. Goldenring, and T.C. Wang Gastric cancer originating from bone marrow-derived cells Science 306 2004 1568 1571
2. M. Karin, T. Lawrence, and V. Nizet Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer Cell 124 2006 823 835
3. H. Kuper, H.O. Adami, and D. Trichopoulos Infections as a major preventable cause of human cancer J Intern Med 248 2000 171 183
4. J. Vakkila, and M.T. Lotze Inflammation and necrosis promote tumour growth Nat Rev Immunol 4 2004 641 648
5. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
6. J. Condeelis, and J.W. Pollard Macrophages: obligate partners for tumor cell migration, invasion, and metastasis Cell 124 2006 263 266
7. J. Wyckoff, W. Wang, E.Y. Lin, Y. Wang, F. Pixley, E.R. Stanley, T. Graf, J.W. Pollard, J. Segall, and J. Condeelis A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors Cancer Res 64 2004 7022 7029
8. E.Y. Lin, J.F. Li, L. Gnatovskiy, Y. Deng, L. Zhu, D.A. Grzesik, H. Qian, X.N. Xue, and J.W. Pollard Macrophages regulate the angiogenic switch in a mouse model of breast cancer Cancer Res 66 2006 11238 11246
9. E.Y. Lin, and J.W. Pollard Tumor-associated macrophages press the angiogenic switch in breast cancer Cancer Res 67 2007 5064 5066
10. F. Balkwill Cancer and the chemokine network Nat Rev Cancer 4 2004 540 550
11. G.J. Bates, S.B. Fox, C. Han, R.D. Leek, J.F. Garcia, A.L. Harris, and A.H. Banham Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse J Clin Oncol 24 2006 5373 5380
12. D.G. DeNardo, J.B. Barreto, P. Andreu, L. Vasquez, D. Tawfik, N. Kolhatkar, and L.M. Coussens CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages Cancer Cell 16 2009 91 102
13. D.G. DeNardo, and L.M. Coussens Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression Breast Cancer Res 9 2007 212
14. A.H. Lee, L.C. Happerfield, L.G. Bobrow, and R.R. Millis Angiogenesis and inflammation in invasive carcinoma of the breast J Clin Pathol 50 1997 669 673
15. R.D. Leek, and A.L. Harris Tumor-associated macrophages in breast cancer J Mammary Gland Biol Neoplasia 7 2002 177 189
16. R.D. Leek, C.E. Lewis, R. Whitehouse, M. Greenall, J. Clarke, and A.L. Harris Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma Cancer Res 56 1996 4625 4629
17. N. Volodko, A. Reiner, M. Rudas, and R. Jakesz Tumour-associated macrophages in breast cancer and their prognostic correlations Breast 7 1998 99 105
18. A. Mantovani, P. Allavena, and A. Sica Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression Eur J Cancer 40 2004 1660 1667
19. A. Mantovani, S. Sozzani, M. Locati, P. Allavena, and A. Sica Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends Immunol 23 2002 549 555
20. J.A. Van Ginderachter, K. Movahedi, G. Hassanzadeh Ghassabeh, S. Meerschaut, A. Beschin, G. Raes, and P. De Baetselier Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion Immunobiology 211 2006 487 501
21. F.O. Martinez, and S. Gordon The M1 and M2 paradigm of macrophage activation: time for reassessment F1000Prime Rep 6 2014 13
22. V. Bronte, and P. Zanovello Regulation of immune responses by L-arginine metabolism Nat Rev Immunol 5 2005 641 654
23. C.I. Chang, J.C. Liao, and L. Kuo Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity Cancer Res 61 2001 1100 1106
24. R.A. Franklin, W. Liao, A. Sarkar, M.V. Kim, M.R. Bivona, K. Liu, E.G. Pamer, and M.O. Li The cellular and molecular origin of tumor-associated macrophages Science 344 2014 921 925
25. E. Bianchi, R.L. Cohen, A.T. Thor, R.F. Todd 3rd, I.F. Mizukami, D.A. Lawrence, B.M. Ljung, M.A. Shuman, and H.S. Smith The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue Cancer Res 54 1994 861 866
26. P.J. Cozzi, J. Wang, W. Delprado, M.C. Madigan, S. Fairy, P.J. Russell, and Y. Li Evaluation of urokinase plasminogen activator and its receptor in different grades of human prostate cancer Hum Pathol 37 2006 1442 1451
27. P.A. Andreasen, L. Kjoller, L. Christensen, and M.J. Duffy The urokinase-type plasminogen activator system in cancer metastasis: a review Int J Cancer 72 1997 1 22
28. C.E. de Bock, and Y. Wang Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer Med Res Rev 24 2004 13 39
29. F. Blasi, and P. Carmeliet uPAR: a versatile signalling orchestrator Nat Rev Mol Cell Biol 3 2002 932 943
30. D.H. Nguyen, I.M. Hussaini, and S.L. Gonias Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility J Biol Chem 273 1998 5802 8507
31. C.D. Madsen, G.M. Ferraris, A. Andolfo, O. Cunningham, and N. Sidenius uPAR-induced cell adhesion and migration: vitronectin provides the key J Cell Biol 177 2007 927 939
32. B.M. Eastman, M. Jo, D.L. Webb, S. Takimoto, and S.L. Gonias A transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogen Cell Signal 24 2012 1847 1855
33. Z. Ma, D.J. Webb, M. Jo, and S.L. Gonias Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells J Cell Sci 114 2001 3387 3396
34. L. Ossowski, and J.A. Aguirre-Ghiso Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth Curr Opin Cell Biol 12 2000 613 620
35. L. Kjøller, and A. Hall Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin J Cell Biol 152 2001 1145 1157
36. R.D. Lester, M. Jo, V. Montel, S. Takimoto, and S.L. Gonias uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells J Cell Biol 178 2007 425 436
37. M. Jo, S. Takimoto, V. Montel, and S.L. Gonias The urokinase receptor promotes cancer metastasis independently of urokinase-type plasminogen activator in mice Am J Pathol 175 2009 190 200
38. M. Jo, B.M. Eastman, D.L. Webb, K. Stoletov, R. Klemke, and S.L. Gonias Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells Cancer Res 70 2010 8948 8958
39. J. Hu, M. Jo, W.K. Cavenee, F. Furnari, S.R. VandenBerg, and S.L. Gonias Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells Proc Natl Acad Sci USA 108 2011 15984 15989
40. N.D. Staudt, M. Jo, J. Hu, J.M. Bristow, D.P. Pizzo, A. Gaultier, S.R. VandenBerg, and S.L. Gonias Myeloid cell receptor LRP1/CD91 regulates monocyte recruitment and angiogenesis in tumors Cancer Res 73 2013 3902 3912
41. A. Mukasa, J. Wykosky, K.L. Ligon, L. Chin, W.K. Cavenee, and F. Furnari Mutant EGFR is required for maintenance of glioma growth in vivo, and its ablation leads to escape from receptor dependence Proc Natl Acad Sci USA 107 2010 2616 2621
42. X. Zhang, R. Goncalves, and D.M. Mosser The isolation and characterization of murine macrophages Curr Protoc Immunol 2008 Chapter 14:Unit 14.1
43. D. Kepka-Lenhart, D.E. Ash, and S.M. Morris Determination of mammalian arginase activity Methods Enzymol 440 2008 221 230
44. C.J. Aslakson, and F.R. Miller Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor Cancer Res 52 1992 1399 1405
45. Z. Mi, H. Guo, P.Y. Wai, C. Gao, and P.C. Kuo Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells Carcinogenesis 27 2006 1134 1145
46. R.A. Flavell, S. Sanjabi, S.H. Wrzesinski, and P. Licona-Limón The polarization of immune cells in the tumour environment by TGFbeta Nat Rev Immunol 10 2010 554 567
47. N.L. Harthun, A.M. Weaver, L.H. Brinckerhoff, D.H. Deacon, S.L. Gonias, and C.L. Slingluff Jr. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2 J Immunother 21 1998 85 94
48. T.J. Standiford, R. Kuick, U. Bhan, J. Chen, M. Newstead, and V.G. Keshamouni TGF-beta-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth Oncogene 30 2011 2475 2484
49. H. Luo, Y. Hao, B. Tang, D. Zeng, Y. Shi, and P. Yu Mouse forestomach carcinoma cells immunosuppress macrophages through transforming growth factor-β1 Mol Med Rep 5 2012 988 992
50. J. Peng, J.Y. Tsang, D. Li, N. Niu, D.H. Ho, K.F. Lau, V.C. Lui, J.R. Lamb, Y. Chen, and P.K. Tam Inhibition of TGF-β signaling in combination with TLR7 ligation re-programs a tumoricidal phenotype in tumor-associated macrophages Cancer Lett 331 2013 239 249
51. L.E. Odekon, F. Blasi, and D.B. Rifkin Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta J Cell Physiol 158 1994 398 407
52. B.I. Gerwin, J. Keski-Oja, M. Seddon, J.F. Lechner, and C.C. Harris TGF-beta 1 modulation of urokinase and PAI-1 expression in human bronchial epithelial cells Am J Physiol 259 1990 L262 L269
53. D.J. Webb, K.S. Thomas, and S.L. Gonias Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth J Cell Biol 152 2001 741 752
54. T.E. Taylor, F.B. Furnari, and W.K. Cavenee Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance Curr Cancer Drug Targets 12 2012 197 209